碳素酸生物异构剂 提高Nurr1主因子的选择性
Tanja Stiller1, Christian Gege2, Wael Saeb3
1Department of Pharmacy, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.
研究人员开发了一种新型的Nurr1激动剂,来自vidofludimus,可以选择性地准Nurr1而不抑制DHODH. 这种新化合物通过促进神经元健康,显示出治疗神经退行性疾病的潜力.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 与核受体相关的1 (Nurr1) 是神经元发育和功能中的关键转录因子.
- Nurr1功能障碍与神经退行性疾病 (如帕金森氏症和阿尔茨海默氏症) 有关.
- 维多弗鲁迪马斯 (Vidofludimus) 是一种DHODH抑制剂,也起到Nurr1激动剂的作用,呈现出一种潜在的治疗途径.
研究的目的:
- 开发一种选择性Nurr1激动剂,这种激动剂来自于vidofludimus.
- 创建一个可以激活Nurr1而不会抑制二基酸脱酶 (DHODH) 的研究工具.
- 研究Nurr1激活在神经退行性疾病中的治疗潜力.
主要方法:
- 在vidofludimus中的碳酸盐基因的生物异构替代.
- 新型Nurr1激动剂的合成和表征.
- 测试以确定Nurr1激动性和DHODH抑制功效.
- 用优化的激动剂治疗多巴胺能神经细胞.
主要成果:
- 一种新的基于四醇的Nurr1激动剂成功合成.
- 这种新化合物对Nurr1比DHODH具有>100倍的选择性.
- 在多巴胺细胞中,治疗诱导的基因与神经保护和神经元健康有关.
结论:
- 选择性Nurr1激活可以通过对现有药物的化学修饰来实现.
- 开发的Nurr1激动剂是研究Nurr1在神经退行过程中的作用的宝贵工具.
- 准Nurr1对开发神经退行性疾病的新疗法充满希望.
更多相关视频
14:02Optimizing the Genetic Incorporation of Chemical Probes into GPCRs for Photo-crosslinking Mapping and Bioorthogonal Chemistry in Live Mammalian Cells
Published on: April 9, 2018
11:01Preparation and In Vivo Use of an Activity-based Probe for N-acylethanolamine Acid Amidase
Published on: November 23, 2016
相关概念视频
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Dose-Response Relationship: Selectivity and Specificity
